Depending on how much you can afford, how much you can handle, and the protocol of the rest of your pharmacology, your cycle would differ wildly from someone elses
Theres only one problem
A Minnesota physician is quoted in the report saying, I know that the FDA is going to approve this, and I thought, Why are we waiting? Because retatrutide has not completed the FDA approval process, products sold online or through clinics are black market drugs and come with no guarantee of quality, purity, or dosing accuracy
Small-molecule drugs can be incorporated into stimuli-responsive matrices or micelles to control release profiles while maintaining oral bioavailability [98]
[13] The relevance to the blend is indirect but real: whatever glucose-metabolic footprint the GH axis carries when stimulated by an oral secretagogue is a reasonable prior for what a GHRH+GHRP stimulus might do, and long-term data that would actually characterize such risks for this blend simply do not exist